BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 23070984)

  • 1. Correlation of electrocardiographic changes and myocardial fibrosis in patients with hypertrophic cardiomyopathy detected by cardiac magnetic resonance imaging.
    Song BG; Yang HS; Hwang HK; Kang GH; Park YH; Chun WJ; Oh JH
    Clin Cardiol; 2013 Jan; 36(1):31-5. PubMed ID: 23070984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High ECG Risk-Scores Predict Late Gadolinium Enhancement on Magnetic Resonance Imaging in HCM in the Young.
    Österberg AW; Östman-Smith I; Jablonowski R; Carlsson M; Green H; Gunnarsson C; Liuba P; Fernlund E
    Pediatr Cardiol; 2021 Mar; 42(3):492-500. PubMed ID: 33515326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial perfusion reserve quantified by cardiac magnetic resonance imaging is associated with late gadolinium enhancement in hypertrophic cardiomyopathy.
    Tezuka D; Kosuge H; Terashima M; Koyama N; Kishida T; Tada Y; Suzuki JI; Sasano T; Ashikaga T; Hirao K; Isobe M
    Heart Vessels; 2018 May; 33(5):513-520. PubMed ID: 29168014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between electrocardiographic changes and CMR features in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy.
    Chen X; Zhao T; Lu M; Yin G; Xiangli W; Jiang S; Prasad S; Zhao S
    Int J Cardiovasc Imaging; 2014 Jun; 30 Suppl 1():55-63. PubMed ID: 24723003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Cardiac Magnetic Resonance Feature Tracking (CMR-FT) Analysis for Detection of Myocardial Fibrosis in Pediatric Hypertrophic Cardiomyopathy.
    Bogarapu S; Puchalski MD; Everitt MD; Williams RV; Weng HY; Menon SC
    Pediatr Cardiol; 2016 Apr; 37(4):663-73. PubMed ID: 26833321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ventricular late potentials and myocardial fibrosis in hypertrophic cardiomyopathy.
    Matsuki A; Kawasaki T; Kawamata H; Sakai C; Harimoto K; Kamitani T; Yamano M; Matoba S
    J Electrocardiol; 2020; 58():87-91. PubMed ID: 31790854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-wave inversions related to left ventricular basal hypertrophy and myocardial fibrosis in non-apical hypertrophic cardiomyopathy: a cardiovascular magnetic resonance imaging study.
    Chen X; Zhao S; Zhao T; Lu M; Yin G; Jiang S; Prasad S
    Eur J Radiol; 2014 Feb; 83(2):297-302. PubMed ID: 24332848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extent of myocardial hyperenhancement on late gadolinium-enhanced cardiovascular magnetic resonance correlates with q waves in hypertrophic cardiomyopathy.
    Papavassiliu T; Flüchter S; Haghi D; Süselbeck T; Wolpert C; Dinter D; Kühl H; Borggrefe M
    J Cardiovasc Magn Reson; 2007; 9(3):595-603. PubMed ID: 17365241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrocardiographic predictors of myocardial fibrosis and apical hypertrophic cardiomyopathy.
    Tangwiwat C; Kaolawanich Y; Krittayaphong R
    Ann Noninvasive Electrocardiol; 2019 Mar; 24(2):e12612. PubMed ID: 30403441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. QRS-T angle in patients with Hypertrophic Cardiomyopathy - A comparison with Cardiac Magnetic Resonance Imaging.
    Jensen CJ; Lambers M; Zadeh B; Wambach JM; Nassenstein K; Bruder O
    Int J Med Sci; 2021; 18(3):821-825. PubMed ID: 33437218
    [No Abstract]   [Full Text] [Related]  

  • 11. 3.0 T magnetic resonance myocardial perfusion imaging for semi-quantitative evaluation of coronary microvascular dysfunction in hypertrophic cardiomyopathy.
    Yin L; Xu HY; Zheng SS; Zhu Y; Xiao JX; Zhou W; Yu SS; Gong LG
    Int J Cardiovasc Imaging; 2017 Dec; 33(12):1949-1959. PubMed ID: 28612277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrocardiography based prediction of hypertrophy pattern and fibrosis amount in hypertrophic cardiomyopathy: comparative study with cardiac magnetic resonance imaging.
    Park CH; Chung H; Kim Y; Kim JY; Min PK; Lee KA; Yoon YW; Kim TH; Lee BK; Hong BK; Rim SJ; Kwon HM; Choi EY
    Int J Cardiovasc Imaging; 2018 Oct; 34(10):1619-1628. PubMed ID: 29728953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of basal-septal fibrosis with LV outflow tract obstruction in hypertrophic cardiomyopathy: insights from cardiac magnetic resonance analysis.
    Nakamura T; Iwanaga Y; Yasuda M; Kawamura T; Miyaji Y; Morooka H; Miyazaki S
    Int J Cardiovasc Imaging; 2016 Apr; 32(4):613-20. PubMed ID: 26589516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous contrast T1rho cardiac magnetic resonance for myocardial fibrosis in hypertrophic cardiomyopathy patients.
    Wang C; Zheng J; Sun J; Wang Y; Xia R; Yin Q; Chen W; Xu Z; Liao J; Zhang B; Gao F
    J Cardiol; 2015 Dec; 66(6):520-6. PubMed ID: 25981868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fragmented QRS on electrocardiography as a predictor of myocardial scar in patients with hypertrophic cardiomyopathy.
    Ratheendran AC; Subramanian M; Bhanu DK; Prabhu MA; Kannan R; Natarajan KU; Saritha Sekhar S; Thachathodiyil R; Harikrishnan MS; Pai PG
    Acta Cardiol; 2020 Feb; 75(1):42-46. PubMed ID: 30602338
    [No Abstract]   [Full Text] [Related]  

  • 16. Frequency and distribution of late gadolinium enhancement in magnetic resonance imaging of patients with apical hypertrophic cardiomyopathy and patients with asymmetrical hypertrophic cardiomyopathy: a comparative study.
    Yamada M; Teraoka K; Kawade M; Hirano M; Yamashina A
    Int J Cardiovasc Imaging; 2009 Apr; 25 Suppl 1():131-8. PubMed ID: 19165622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Focal ischemic myocardial fibrosis assessed by late gadolinium enhancement cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy.
    Zhi Y; Gui FD; Xue M; Long YT; Miao W; Yi Y; Gao LC; Bing F; Pan SY
    BMC Cardiovasc Disord; 2024 Apr; 24(1):203. PubMed ID: 38594610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How are ECG parameters related to cardiac magnetic resonance images? Electrocardiographic predictors of left ventricular hypertrophy and myocardial fibrosis in hypertrophic cardiomyopathy.
    Dohy Z; Vereckei A; Horvath V; Czimbalmos C; Szabo L; Toth A; Suhai FI; Csecs I; Becker D; Merkely B; Vago H
    Ann Noninvasive Electrocardiol; 2020 Sep; 25(5):e12763. PubMed ID: 32329134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of Hypertrophy and Late Gadolinium Enhancement in Children and Adolescents with Hypertrophic Cardiomyopathy.
    Windram JD; Benson LN; Dragelescu A; Yoo SJ; Mertens L; Wong D; Grosse-Wortmann L
    Congenit Heart Dis; 2015; 10(6):E258-67. PubMed ID: 26193909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial scarring on cardiovascular magnetic resonance in asymptomatic or minimally symptomatic patients with "pure" apical hypertrophic cardiomyopathy.
    Kim KH; Kim HK; Hwang IC; Lee SP; Park EA; Lee W; Kim YJ; Park JH; Sohn DW
    J Cardiovasc Magn Reson; 2012 Jul; 14(1):52. PubMed ID: 22839526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.